{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:16:43Z","timestamp":1790799403714,"version":"4.1.0"},"reference-count":29,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>There is a disproportionately high rate of overdose deaths immediately following an emergency department (ED) visit for opioid overdose. Thus, an improved understanding of disparities in ED treatment and referral is vital. Racial and ethnic disparities in access to naloxone and buprenorphine have been described in the outpatient setting but prevalence in the ED setting remains understudied.<\/jats:p><\/jats:sec>Objective<\/jats:title>To examine racial and ethnic disparities in treatment referral rates in ED patients with opioid overdose.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This is a secondary analysis of a prospective consecutive cohort from the Toxicology Investigators Consortium (TOXIC) Fentalog Study from September 21, 2020, to November 11, 2023. Ten hospital sites were a part of the TOXIC network and participants included ED patients in aged 18 years or older with opioid overdose. Data were analyzed from December 2022 to March 2025.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Patient race, ethnicity, sex, and other demographic and clinical factors of interest.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Study outcomes included the proportion of patients receiving a referral to outpatient addiction care and the proportion receiving a naloxone kit or prescription or buprenorphine prescription at discharge. Descriptive statistics were tabulated, and \u03c72<\/jats:sup> and multivariable logistic regression analyses were used to evaluate for differences by race, ethnicity, sex, and other demographic and clinical variables.<\/jats:p><\/jats:sec>Results<\/jats:title>In this study, 1683 patients met all inclusion criteria (mean [SD] age, 42.5 [14.5] years; 1221 males [72.6%]; 461 females [27.4%]; 447 Black patients [26.6%]; 63 Hispanic patients [4.3%]; 867 White patients [51.5%]). Of the 1683 included patients, 299 (17.8%) received a referral for outpatient treatment, 713 (42.4%) received a naloxone kit or prescription, and 141 (8.4%) received a buprenorphine prescription. Compared with White patients, Black patients had a decreased adjusted odds ratio (aOR) of outpatient treatment referral (aOR, 0.67; 95% CI, 0.47-0.97). Hospital admission was also associated with increased adjusted odds of outpatient treatment referral (aOR, 3.13; 95% CI, 2.34-4.20). Geographic variation was associated with all primary and secondary outcomes.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this study, Black patients were less likely to receive outpatient referrals for OUD. These findings underscore the need for targeted interventions to address racial disparities in ED care for OUD, particularly in enhancing referral processes.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.18569","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:00:29Z","timestamp":1751468429000},"page":"e2518569","source":"Crossref","is-referenced-by-count":5,"title":["Disparities in Treatment and Referral After an Opioid Overdose Among Emergency Department Patients"],"prefix":"10.1001","volume":"8","author":[{"given":"Siri","family":"Shastry","sequence":"first","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Carpenter","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine, Atlanta, Georgia"},{"name":"Grady Health System, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Krotulski","sequence":"additional","affiliation":[{"name":"Center for Forensic Science Research and Education, Fredric Rieders Family Foundation, Horsham, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Brent","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Wax","sequence":"additional","affiliation":[{"name":"American College of Medical Toxicology, Phoenix, Arizona"},{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Aldy","sequence":"additional","affiliation":[{"name":"American College of Medical Toxicology, Phoenix, Arizona"},{"name":"University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharan","family":"Campleman","sequence":"additional","affiliation":[{"name":"American College of Medical Toxicology, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Culbreth","sequence":"additional","affiliation":[{"name":"American College of Medical Toxicology, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Falise","sequence":"additional","affiliation":[{"name":"American College of Medical Toxicology, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Hughes","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Hendrickson","sequence":"additional","affiliation":[{"name":"Oregon Health and Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Amaducci","sequence":"additional","affiliation":[{"name":"Lehigh Valley Health Network\/USF Morsani College of Medicine, Allentown, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Judge","sequence":"additional","affiliation":[{"name":"Corewell Health, Michigan State University, Grand Rapids"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Meaden","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane P.","family":"Calello","sequence":"additional","affiliation":[{"name":"Rutgers New Jersey Medical School, Newark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Buchanan","sequence":"additional","affiliation":[{"name":"Denver Health and Hospital Authority, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Shulman","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Levine","sequence":"additional","affiliation":[{"name":"University of California Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Schwarz","sequence":"additional","affiliation":[{"name":"University of California Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex F.","family":"Manini","sequence":"additional","affiliation":[{"name":"Icahn School of Medicine at Mount Sinai, Center for Research on Emerging Substances, Poisoning, Overdose, and New Discoveries (RESPOND), Department of Emergency Medicine, New York, New York"},{"name":"Elmhurst Hospital Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"issue":"25","key":"zoi250582r1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates\u2014United States, 2022.","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"zoi250582r2","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMp1811988","article-title":"Emergency departments\u2014a 24\/7\/365 option for combating the opioid crisis.","volume":"379","author":"D\u2019Onofrio","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi250582r3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/10826084.2022.2046098","article-title":"Emergency department utilization patterns in patients with opioid-related emergency department visits.","volume":"57","author":"Shastry","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"16","key":"zoi250582r4","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","article-title":"Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial.","volume":"313","author":"D\u2019Onofrio","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"zoi250582r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.53771","article-title":"Emergency department access to buprenorphine for opioid use disorder.","volume":"7","author":"Herring","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi250582r6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.21209","article-title":"Trends in the use of buprenorphine in US emergency departments, 2002-2017.","volume":"3","author":"Rhee","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"7","key":"zoi250582r7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/acem.14668","article-title":"Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.","volume":"30","author":"Holland","year":"2023","journal-title":"Acad Emerg Med"},{"issue":"3","key":"zoi250582r8","first-page":"303","article-title":"Addressing system and clinician barriers to emergency department-initiated buprenorphine: an evaluation of post-intervention physician outcomes.","volume":"25","author":"Mahal","year":"2024","journal-title":"West J Emerg Med"},{"issue":"1","key":"zoi250582r9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.annemergmed.2019.04.020","article-title":"One-year mortality of patients after emergency department treatment for nonfatal opioid overdose.","volume":"75","author":"Weiner","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"4","key":"zoi250582r10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1080\/08897077.2016.1152342","article-title":"Emergency department presentation and mortality rate due to overdose: a retrospective cohort study on nonfatal overdoses.","volume":"37","author":"Pavarin","year":"2016","journal-title":"Subst Abus"},{"issue":"3","key":"zoi250582r11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"5","key":"zoi250582r12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients.","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi250582r13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.annemergmed.2021.10.005","article-title":"Naloxone and Buprenorphine prescribing following US emergency department visits for suspected opioid overdose: August 2019 to April 2021.","volume":"79","author":"Chua","year":"2022","journal-title":"Ann Emerg Med"},{"issue":"3","key":"zoi250582r14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019.","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"9596","key":"zoi250582r15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"zoi250582r16","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.13235","article-title":"Heroin or fentanyl: prevalence of confirmed fentanyl in ED patients with suspected heroin overdose.","volume":"5","author":"Shastry","year":"2024","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"zoi250582r17","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2024.100223","article-title":"Psychostimulant drug co-ingestion in non-fatal opioid overdose.","volume":"10","author":"Shastry","year":"2024","journal-title":"Drug Alcohol Depend Rep"},{"key":"zoi250582r18","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1553-2712.2001.tb01115.x","article-title":"America\u2019s health care safety net: intact or unraveling?","volume":"8","author":"Richardson","year":"2001","journal-title":"Acad Emerg Med"},{"issue":"12","key":"zoi250582r19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/acem.13134","article-title":"Shared decision making with vulnerable populations in the emergency department.","volume":"23","author":"Castaneda-Guarderas","year":"2016","journal-title":"Acad Emerg Med"},{"issue":"12","key":"zoi250582r20","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/15563650.2018.1478425","article-title":"Racial disparities in the treatment of acute overdose in the emergency department.","volume":"56","author":"Wilder","year":"2018","journal-title":"Clin Toxicol (Phila)"},{"issue":"1","key":"zoi250582r21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ajem.2018.05.044","article-title":"Naloxone prescriptions from the emergency department: an initiative in evolution.","volume":"37","author":"Verdier","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"4","key":"zoi250582r22","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.annemergmed.2017.07.232","article-title":"254 Rates of naloxone prescriptions following implementation of a take-home naloxone program from the emergency department.","volume":"70","author":"Lebin","year":"2017","journal-title":"Ann Emerg Med"},{"issue":"10","key":"zoi250582r23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/10810730.2019.1669742","article-title":"Does discrimination breed mistrust? examining the role of mediated and nonmediated discrimination experiences in medical mistrust.","volume":"24","author":"Williamson","year":"2019","journal-title":"J Health Commun"},{"key":"zoi250582r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108551","article-title":"Experiences of racial discrimination in the medical setting and associations with medical mistrust and expectations of care among black patients seeking addiction treatment.","volume":"133","author":"Hall","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"zoi250582r25","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1525-1497.2004.30227.x","article-title":"Why do providers contribute to disparities and what can be done about it?","volume":"19","author":"Burgess","year":"2004","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi250582r26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jemermed.2023.01.012","article-title":"Methadone initiation in the emergency department for opioid use disorder: a case series.","volume":"64","author":"Huo","year":"2023","journal-title":"J Emerg Med"},{"issue":"19","key":"zoi250582r27","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder.","volume":"388","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi250582r28","doi-asserted-by":"publisher","first-page":"e590","DOI":"10.1016\/j.jemermed.2024.05.016","article-title":"Factors associated with take home naloxone refusal among emergency department patients participating in an opioid overdose prevention program.","volume":"67","author":"O\u2019Brien-Lambert","year":"2024","journal-title":"J Emerg Med"},{"issue":"2","key":"zoi250582r29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1017\/cem.2018.368","article-title":"Yes, not now, or never: an analysis of reasons for refusing or accepting emergency department-based take-home naloxone.","volume":"21","author":"Kestler","year":"2019","journal-title":"CJEM"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2835884\/shastry_2025_oi_250582_1750878877.75028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T15:00:30Z","timestamp":1751468430000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2835884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.18569","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}